Among 25 hemodialysis patients with end-stage renal failure due to diabetic nephropathy, 20 (80%) were on insulin treatment, 1 (4%) patient was treated with sulphonylurea in monotherapy, while others (16%) were on diet. The gene discussed is INS; the disease is stage 5 chronic kidney disease.